Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa massachusetts
  4. inflammatory anti
Show results for
Products
Services
Applications

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Massachusetts
Brands

  • lyra
  • aobiome
  • biotest
  • emulate
  • targetmol
View all brands
Applications

  • Clinical Immunology and Intensive Care Medicine for Haemophilia
  • Clinical Immunology and Intensive Care Medicine for Immunoglobulins
  • Clinical Immunology and Intensive Care Medicine for Antibody Deficiency

Inflammatory Anti Equipment Supplied In Usa Massachusetts

8 equipment items found
In MassachusettsAvailable In MassachusettsNear Massachusetts

Model ADS032 - Respiratory Inflammation

Model ADS032 - Respiratory Inflammation

Manufactured by:Adiso Therapeutics   based inConcord, MASSACHUSETTS (USA)
Chronic activation of NLRP1 and NLPR3 is directly implicated in a wide range of inflammation-triggered conditions across multiple organ systems. By targeting both NLRP3 and NLRP1, ADS032 may provide a comprehensive anti-inflammatory approach across a range of diseases. ...
CONTACT SUPPLIER

YSOPIA - Model Yso2 - Develop Christensenella Gut Bacteria

YSOPIA - Model Yso2 - Develop Christensenella Gut Bacteria

by:Verb Biotics   based inBoston, MASSACHUSETTS (USA)
Discover the articles we published in Scientific Reports: Relizani et al. 2022 and Kropp et al. 2021. Our team has selected from our proprietary strain library a lead candidate with high anti-inflammatory potential and protective action on gut ...
CONTACT SUPPLIER

TargetMol - Model GLPG3312 - Selective Pan-SIK Inhibitor

TargetMol - Model GLPG3312 - Selective Pan-SIK Inhibitor

Manufactured by:TargetMol Chemicals Inc.   based inWellesley Hills, MASSACHUSETTS (USA)
GLPG3312 is a selective and potent pan-SIK inhibitor with the advantage of oral activity, with IC50=0.6-2.0 nM for SIK1, SIK2 and SIK3, and exhibits anti-inflammatory and immunomodulatory activity in both human primary myeloid cells and mouse ...
CONTACT SUPPLIER

Lyra - Model LYR-220 - Long-acting Mometasone Furoate

Lyra - Model LYR-220 - Long-acting Mometasone Furoate

Manufactured by:Lyra Therapeutics, Inc.   based inWatertown, MASSACHUSETTS (USA)
LYR-220, Lyra’s second product candidate, is in Phase 2 development for the millions of chronic rhinosinusitis (CRS) patients who have undergone a prior sinus surgery but continue to have persistent ...
CONTACT SUPPLIER

Lyra - Model LYR-210 - Innovative Therapeutic Solution for CRS

Lyra - Model LYR-210 - Innovative Therapeutic Solution for CRS

Manufactured by:Lyra Therapeutics, Inc.   based inWatertown, MASSACHUSETTS (USA)
Lyra’s lead product candidate, LYR-210, to treat chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses. LYR-210 is an anti-inflammatory implantable drug matrix based upon Lyra’s XTreo™ platform designed to elute mometasone furoate consistently and locally to the inflamed mucosal tissue of ...
CONTACT SUPPLIER

AOBiome - Human Microbiome

AOBiome - Human Microbiome

Manufactured by:AOBiome Therapeutic, LLC   based inCambridge, MASSACHUSETTS (USA)
The human microbiome consists of hundreds of trillions of microorganisms, outnumbering human cells by 10 to 1 with as many as 3 million bacterial genes to our approximately 20 thousand. While the microbiome has recently become an area of active research, its overall effects on human health remain largely ...
CONTACT SUPPLIER

Emulate - Colon Intestine-Chip

Emulate - Colon Intestine-Chip

Manufactured by:Emulate   based inBoston, MASSACHUSETTS (USA)
Investigate mechanisms of colon inflammation and barrier disruption and evaluate the efficacy of anti-inflammatory drug candidates in an organoid-derived ...
CONTACT SUPPLIER

Biotest - Model BT588 - Severe Community Acquired Pneumonia Pipeline

Biotest - Model BT588 - Severe Community Acquired Pneumonia Pipeline

Manufactured by:Biotest AG   based inDreieich, GERMANY
Trimodulin mediates its mode of action via three potential mechanisms which are; opsonization of causal pathogens, neutralizing of microbial pathogens and their virulence factors (endo- and exotoxins) and targeting the host inflammatory response (anti-inflammatory properties). Currently, trimodulin is under clinical development for severe ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT